An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy
Status:
Completed
Trial end date:
2021-05-18
Target enrollment:
Participant gender:
Summary
SP848 is an open-label study to evaluate long-term safety, tolerability, and efficacy in
children with epilepsy treated with Lacosamide (LCM) oral solution (syrup) or LCM tablets as
adjunctive therapy.